Ignite Creation Date:
2025-12-24 @ 1:30 PM
Ignite Modification Date:
2026-02-25 @ 2:31 AM
Study NCT ID:
NCT00464295
Status:
COMPLETED
Last Update Posted:
2007-12-14
First Post:
2007-04-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)
Sponsor:
Aga Khan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-10
Completion Date Type:
ACTUAL
First Submit Date:
2007-04-20
First Submit QC Date:
None
Study First Post Date:
2007-04-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-12-13
Last Update Post Date:
2007-12-14
Last Update Post Date Type:
ESTIMATED